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ABSTRACT 
Plasmodium falciparum malaria is a significant public health concern particularly in Sub-
Saharan Africa. Effective malaria vaccines will contribute significantly towards controlling 
the disease but their development is hampered by the incomplete understanding of immunity 
to malaria. Whereas naturally acquired immunity is known to have an important antibody 
mediated component, the targets and functional correlates as well longevity of these responses 
are largely unknown and merit further understanding. The studies presented in this thesis, 
investigate several aspects of naturally acquired immunity to some of the major merozoite 
vaccine candidate antigens. 
In longitudinally monitored children in Tanzania, antibody responses against seven merozoite 
surface antigens were investigated in relation to the genetic diversity of P. falciparum 
infections, as determined by genotyping of one of the merozoite surface protein genes. The 
breadth of anti-merozoite antibody responses was positively correlated with the number of 
concurrent P. falciparum clones in asymptomatic children. Further, broad antibody responses 
and genetically diverse infections, in combination, were more strongly associated with 
protection against malaria than they were individually suggesting that multicomponent 
malaria vaccines mimicking naturally acquired immunity should ideally induce antibody 
responses that can be boosted by natural infections. 
The inhibitory activity of naturally acquired antibodies on the in vitro growth of P. falciparum 
in relation to merozoite invasion phenotype was investigated in a case-control study in 
Tanzanian children. The growth-inhibitory activities (GIA) of plasma were different when 
tested on different parasite lines. The association between GIA and protection against clinical 
malaria was also parasite line-dependent thus emphasizing the importance of invasion 
phenotypes as well as the need to consider the choice of parasite lines in the use of GIA as a 
correlate of protection against clinical malaria in epidemiological and vaccine studies. 
Within a longitudinally monitored population in Kenya, temporal dynamics of anti-merozoite 
antibody responses were investigated in children with different susceptibilities to malaria. 
Overall, antibody levels were similar in children experiencing multiple episodes or only single 
episodes suggesting that differences in disease susceptibility are not attributable to differences 
in the acquisition of anti-merozoite antibody responses, and may be explained by other 
factors, such as differences in the intensity of exposure to the parasite in this setting of low-
moderate malaria transmission. 
To investigate the longevity of immune responses induced by natural P. falciparum 
infections, circulating merozoite antigen-specific antibodies and memory B-cells (MBCs) 
were studied in travelers who had been diagnosed and treated for malaria in Stockholm 1-16 
years previously. P. falciparum-specific MBCs, but not antibodies, were found to have been 
maintained for up to 16 years without re-exposure to the parasite.  
 
In conclusion, single natural P. falciparum infections induce long-lived memory-B cell 
responses to merozoite antigens, however, broad and protective antibody responses require 
repeated exposure and preferably persistent genetically diverse infections to confer clinical 
immunity to malaria. Taken together, these studies advance the understanding of naturally 
acquired immunity to malaria and have important implications for the development of malaria 
vaccines.  
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